DAIICHI SANKYO CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,502 JPY | +3.13% |
|
+9.82% | +42.10% |
| 04-30 | Remsons, Daiichi Infotainments Form Joint Venture | MT |
| 04-29 | AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DAIICHI SANKYO CO., LTD. | Other Pharmaceuticals | +3.13% | +9.82% | +42.10% | +17.39% | +201.15% | 69B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4568 Stock
- Charts Daiichi Sankyo Co., Ltd.
- Comparison Chart
